Drug Shortage Report for MINT-METFORMIN
Report ID | 74455 |
Drug Identification Number | 02388766 |
Brand name | MINT-METFORMIN |
Common or Proper name | Metformin |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 500 count Bottles |
ATC code | A10BA |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2019-02-04 |
Estimated end date | Unknown |
Actual end date | 2023-11-16 |
Shortage status | Resolved |
Updated date | 2024-12-05 |
Company comments | Business Reasons. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-12-05 | French | Compare |
v4 | 2024-12-05 | English | Compare |
v3 | 2019-02-05 | English | Compare |
v2 | 2019-02-04 | French | Compare |
v1 | 2019-02-04 | English | Compare |
Showing 1 to 5 of 5